Abstract
Bacterial lipopolysaccharide (LPS) was demonstrated to have the capacity in mice to enhance the response to soluble bovine serum albumin (BSA) and to interfere with the induction of tolerance to human γ-globulin (HGG). These adjuvant activities were shown to occur under conditions in which LPS could also function as a B cell mitogen. This positive correlation was established by utilizing two experimental situations in which LPS was non-mitogenic for spleen cells. Thus, on the one hand, it was found that LPS did not function as an adjuvant in C3H/HeJ mice, a unique strain whose spleen cells were also unresponsive to LPS-induced mitogenesis. On the other hand, in strains which did respond to LPS mitogenically, LPS failed to function as an adjuvant when it was chemically altered to reduce its in vitro mitogenic activity. A correlation was also observed between mitogenesis and the capacity of LPS to function as a specific immunogen in mice. In contrast to the sustained and prolonged plaque-forming cell response that was observed in mice whose spleen cells were also responsive to LPS-induced mitogenesis, the response was relatively transient in the C3H/HeJ strain. These results are discussed in view of the possible in vivo modes of action of LPS.
Footnotes
-
↵2 Supported by United States Public Health Service Training Grant AI-00453.
-
↵3 Supported by a Dernham Fellowship (No. D-202) of the California Division of the American Cancer Society.
-
↵4 Supported by United States Public Health Service Training Grant 5-TO1 GM00683-13.
-
↵5 Supported by United States Public Health Research Career Award 5-K6-GM-06936.
-
↵1 This is Publication Number 857 from Experimental Pathology, Scripps Clinic and Research Foundation, La Jolla, California. This work was supported by the United States Public Health Service Grant AI-07007, American Cancer Grant IM-42D and Atomic Energy Commission Contract AT(04-3)-410.
- Received August 9, 1974.
- Copyright © 1975 by The American Association of Immunologists, Inc.
Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$37.50
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.